References
- Dieterle W., Faigle J.W. Preparative liquid-chromatographic methods in drug metabolism studies. Drug Metabolite Isolation and Determination, E. Reid, J.P. Leppard. Plenum Press, New York 1983; 13–32
- Dieterle W., Faigle J.W., Montigel C., Sulc M., Theobald W. Biotransformation and pharmacokinetics of acenocoumarol (Sintrom®) in man. European Journal of Clinical Pharmacology 1977; 11: 367–375
- Dieterle W., Faigle J.W., Mory H. Preparative reversed-phase chromatography of polar and non-polar metabolites on columns packed with micronized XAD-2 resin. Journal of Chromatography 1979; 168: 27–34
- Dieterle W., Faigle J.W., Imhof P., Sulc M., Wagner J. The metabolic fate of [14C]oxaprotiline·HCl in man. I. Disposition and preliminary pharmacokinetics. Xenobiotica 1984a; 14: 303–310
- Dieterle W., Faigle J.W., Kriemler H.P., Winkler T. The metabolic fate of [14C]oxaprotiline·HCl in man. II. Isolation and identification of metabolites. Xenobiotica 1984b; 14: 311–319
- Dieterle W., Faigle J.W., Küng W., Theobald W. The metabolic fate of [14C]oxaprotiline·HCl in man. III. Stereospecific disposition. Biopharmaceutics and Drug Disposition 1984c; 5: 377–386
- Feighner J.D., Roffman M., Dixon R.B. An early clinical trial of oxaprotiline in hospitalized patients with primary depression. Current Therapeutic Research 1981; 29: 363–369
- Roffman M., Gould E.E., Brewer S.J., Lau H., Sachais B., Dixon R.B., Kaczmarek L., LeSher A. A double-blind comparative study of oxaprotiline with amitriptyline and placebo in moderate depression. Current Therapeutic Research 1982; 32: 247–256
- Waldmeier P.C., Baumann P.A., Hauser K., Maître L., Storni A. Oxaprotiline, a noradrenaline uptake inhibitor with an active and inactive enantiomer. Biochemical Pharmacology 1982; 31: 2169–2176
- Winkler T., Dieterle W., Hug P., Kriemler H.P., Rihs G. The structure of diastereomeric oxaprotiline metabolites. An NMR study. Helvetica Chimica Acta 1984; 67: 2082–2086